Susquehanna International Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-16,000
| Closed | -$225K | – | 13257 |
|
|
2023
Q2 | $225K | Sell |
16,000
-4,300
| -21% | -$61.5K | ﹤0.01% | 10034 |
|
|
2023
Q1 | $314K | Sell |
20,300
-71,000
| -78% | -$1.19M | ﹤0.01% | 9623 |
|
|
2022
Q4 | $1.5M | Sell |
91,300
-11,100
| -11% | -$180K | ﹤0.01% | 5298 |
|
|
2022
Q3 | $1.89M | Sell |
102,400
-32,100
| -24% | -$504K | ﹤0.01% | 5017 |
|
|
2022
Q2 | $1.77M | Buy |
134,500
+32,400
| +32% | +$358K | ﹤0.01% | 5171 |
|
|
2022
Q1 | $946K | Sell |
102,100
-322,200
| -76% | -$2.74M | ﹤0.01% | 7275 |
|
|
2021
Q4 | $4.14M | Buy |
424,300
+369,700
| +677% | +$6.95M | ﹤0.01% | 4073 |
|
|
2021
Q3 | $1.85M | Buy |
54,600
+25,100
| +85% | +$801K | ﹤0.01% | 5999 |
|
|
2021
Q2 | $1.08M | Sell |
29,500
-4,900
| -14% | -$190K | ﹤0.01% | 7554 |
|
|
2021
Q1 | $1.54M | Buy |
34,400
+10,100
| +42% | +$470K | ﹤0.01% | 6569 |
|
|
2020
Q4 | $1.39M | Sell |
24,300
-38,300
| -61% | -$2.27M | ﹤0.01% | 5917 |
|
|
2020
Q3 | $3.21M | Sell |
62,600
-22,300
| -26% | -$1.09M | ﹤0.01% | 3739 |
|
|
2020
Q2 | $5.07M | Buy |
84,900
+52,700
| +164% | +$2.82M | ﹤0.01% | 2995 |
|
|
2020
Q1 | $1.33M | Sell |
32,200
-68,500
| -68% | -$3.8M | ﹤0.01% | 4739 |
|
|
2019
Q4 | $6.27M | Buy |
100,700
+37,900
| +60% | +$1.8M | ﹤0.01% | 2664 |
|
|
2019
Q3 | $2.13M | Buy |
62,800
+28,300
| +82% | +$838K | ﹤0.01% | 4057 |
|
|
2019
Q2 | $778K | Buy |
+34,500
| New | +$807K | ﹤0.01% | 6264 |
|
|
2019
Q1 | – | Sell |
-11,600
| Closed | -$243K | – | 10064 |
|
|
2018
Q4 | $243K | Buy |
11,600
+3,400
| +41% | +$83.6K | ﹤0.01% | 7395 |
|
|
2018
Q3 | $318K | Buy |
+8,200
| New | +$303K | ﹤0.01% | 7377 |
|
Other funds holding DCPH
Susquehanna International Group's DCPH Position: Q2 2024 in Review
Susquehanna International Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 58,100 shares — an estimated $914K sold.
Susquehanna International Group first reported a position in DCPH in Q2 2018 and held it in 21 quarters. The position peaked at $5.08M in Q4 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Susquehanna International Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Susquehanna International Group sold 58,100 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $914K.
- Susquehanna International Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 21 quarters.
- Susquehanna International Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $5.08M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.